Skip to content
DataLookout
Menu

TOBY ATLASNCT07933042

A Study of Urine Volatile Organic Compounds for Disease Detection

StatusNot Yet Recruiting
PhaseNot specified
SponsorToby, Inc.
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria changed
    • Study description expanded, about 35 words
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Clinical performance of each locked assay
Timeframe: At specimen collection and reference-standard assessment, including medical-record review at approximately 12 months where available.
Paired comparison with available standard-of-care tests
Timeframe: At specimen collection and reference-standard assessment, including medical-record review at approximately 12 months where available.

Secondary (2)

Assay performance by subgroup and signal origin
Protocol-conforming specimens with final reference-standard classification

Arms and interventions

Target disease cases

Participants with a target disease established by the applicable reference standard, including participants assessed after treatment where specified.

Controls

Participants without the target disease for a given analysis, including healthy participants and participants with other diseases, benign conditions, or negative diagnostic work-ups.